• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Head and neck cancer.

作者信息

Vokes E E, Weichselbaum R R, Lippman S M, Hong W K

机构信息

Department of Medicine, University of Chicago, IL.

出版信息

N Engl J Med. 1993 Jan 21;328(3):184-94. doi: 10.1056/NEJM199301213280306.

DOI:10.1056/NEJM199301213280306
PMID:8417385
Abstract
摘要

相似文献

1
Head and neck cancer.头颈癌
N Engl J Med. 1993 Jan 21;328(3):184-94. doi: 10.1056/NEJM199301213280306.
2
[Recent treatment modality for advanced head and neck carcinomas].[晚期头颈癌的近期治疗方式]
Gan To Kagaku Ryoho. 1998 Sep;25(11):1657-64.
3
Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations.头颈部鳞状细胞癌的治疗管理：欧洲最新治疗建议。
Expert Rev Anticancer Ther. 2010 Mar;10(3):339-44. doi: 10.1586/era.10.6.
4
Is there still a role for induction chemotherapy for head and neck cancer?诱导化疗在头颈癌治疗中仍有作用吗？
J Clin Oncol. 2005 Feb 20;23(6):1059-60. doi: 10.1200/JCO.2005.09.925. Epub 2005 Jan 18.
5
"Skip metastases" from head and neck cancers.头颈部癌症的“跳跃式转移”
Acta Otolaryngol. 2002 Oct;122(7):788-91.
6
Head and neck cancer: state of the art.头颈癌：最新进展
J Med Liban. 1994;42(4):216-20.
7
Head and neck cancer: past, present and future.头颈癌：过去、现在与未来。
Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8. doi: 10.1586/14737140.6.7.1111.
8
Contemporary management of head and neck cancers.头颈部癌症的当代管理。
Isr Med Assoc J. 2009 May;11(5):296-300.
9
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.局部晚期头颈癌患者综合治疗中的颈清扫术
Head Neck. 2004 May;26(5):447-55. doi: 10.1002/hed.10394.
10
Clinical experiences in managing head and neck squamous carcinoma.头颈部鳞状细胞癌的临床治疗经验
Ear Nose Throat J. 1984 Dec;63(12):591-6.

引用本文的文献

1
TRIM47 promotes head and neck squamous cell carcinoma malignant progression by degrading XAF1 through ubiquitination.TRIM47 通过泛素化降解 XAF1 促进头颈部鳞状细胞癌的恶性进展。
iScience. 2024 Dec 13;28(1):111590. doi: 10.1016/j.isci.2024.111590. eCollection 2025 Jan 17.
2
Andrographolide demonstrates anti-proliferative activity in oral cancer by promoting apoptosis, the programmed cell death process.穿心莲内酯通过促进凋亡（程序性细胞死亡过程）在口腔癌中表现出抗增殖活性。
Iran J Basic Med Sci. 2024;27(10):1300-1308. doi: 10.22038/ijbms.2024.76691.16599.
3
LncRNA NR2F2-AS1 inhibits the progression of oral squamous cell carcinoma by mediating the miR-32-5p/SEMA3A axis.
长链非编码 RNA NR2F2-AS1 通过调控 miR-32-5p/SEMA3A 轴抑制口腔鳞状细胞癌的进展。
Kaohsiung J Med Sci. 2024 Oct;40(10):877-889. doi: 10.1002/kjm2.12888. Epub 2024 Aug 23.
4
The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China.帕博利珠单抗治疗复发或转移性头颈部鳞状细胞癌患者的临床结局：一项中国单中心真实世界研究。
Front Oncol. 2024 Feb 19;14:1360657. doi: 10.3389/fonc.2024.1360657. eCollection 2024.
5
Predictive Model for Occurrence of Febrile Neutropenia after Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Retrospective, Observational Study.弥漫性大B细胞淋巴瘤患者化疗后发热性中性粒细胞减少症发生的预测模型：一项多中心、回顾性、观察性研究
Hematol Rep. 2024 Feb 7;16(1):76-88. doi: 10.3390/hematolrep16010008.
6
SIRT1 as a potential key regulator for mediating apoptosis in oropharyngeal cancer using cyclophosphamide and all-trans retinoic acid.使用环磷酰胺和全反式维甲酸，SIRT1 作为调节口咽癌细胞凋亡的潜在关键调节因子。
Sci Rep. 2024 Jan 2;14(1):41. doi: 10.1038/s41598-023-50478-6.
7
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherapy to the PRIMary tumor only. Protocol of the PRIMO study.在口咽、喉或下咽鳞状细胞癌且颈部临床检查阴性的患者中，通过前哨淋巴结活检指导的个性化颈部放疗：仅对原发肿瘤进行（化疗）放疗。PRIMO研究方案。
Clin Transl Radiat Oncol. 2023 Oct 26;44:100696. doi: 10.1016/j.ctro.2023.100696. eCollection 2024 Jan.
8
The genes regulating sensitivity of tumor cells to T cell-mediated killing: could they be potential personalized immunotherapeutic targets in head and neck squamous cell carcinoma?调节肿瘤细胞对T细胞介导杀伤敏感性的基因：它们能否成为头颈部鳞状细胞癌潜在的个性化免疫治疗靶点？
Discov Oncol. 2023 Nov 5;14(1):199. doi: 10.1007/s12672-023-00806-z.
9
The Role of Open Conservation Surgery in the Era of Minimally Invasive Surgery for Hypopharyngeal Cancer.开放式保喉手术在咽喉癌微创时代的作用。
Medicina (Kaunas). 2023 Oct 21;59(10):1873. doi: 10.3390/medicina59101873.
10
Serum autoantibody profiling of oral squamous cell carcinoma patients reveals NUBP2 as a potential diagnostic marker.口腔鳞状细胞癌患者的血清自身抗体谱分析显示NUBP2是一种潜在的诊断标志物。
Front Oncol. 2023 Sep 22;13:1167691. doi: 10.3389/fonc.2023.1167691. eCollection 2023.